Caption Health has entered into an exclusive strategic partnership with Butterfly Network to enable earlier disease detection and management using artificial intelligence (AI)-based guidance and diagnostics.

The partnership aims to develop an integrated solution that helps to enhance cardiac assessment by improving the ease of image capture and interpretation at various levels, including the hospital, clinic and at home.

The new solution will be developed using Caption Health’s FDA-cleared AI-guided ultrasound software, Caption AI, and Butterfly iQ+, a handheld whole-body ultrasound system that uses Butterfly Network’s Ultrasound-on-Chip technology.

This combination will pave the way for a new generation of ultrasound diagnostic platforms.

Butterfly Network president and CEO Todd Fruchterman said: “By combining Butterfly’s differentiated solution with Caption’s AI capabilities, we are accelerating on our promise to provide practitioners with an easy-to-use advanced assessment tool that allows them to make more informed clinical decisions earlier in the patient care journey.

“With this partnership, we are enabling better care that can lead to improved patient outcomes.”

The companies are anticipated to launch the new platform in the US later this year.

Recently, Caption Health’s Caption Guidance received Centers for Medicare and Medicaid Services (CMS) new technology add-on payments (NTAP) authorisation.

Caption Health CEO and president Steve Cashman said: “Our partnership with Butterfly unlocks a new frontier in patient care. This is a pivotal time when imaging can reinvent diagnostic speed and accuracy.

“Butterfly’s comprehensive and versatile whole-body ultrasound solution will now have FDA-cleared AI guidance and interpretation, allowing every healthcare provider the ability to capture and understand cardiac function, and this is only the beginning.”